Events & Presentations
Upcoming Events
Date | Event Details | Remind Me |
---|---|---|
May 9, 2024 4:30 PM EDT
|
Live Teleconference Information
|
|
May 14 - May 17, 2024
|
Title: Preclinical Profile of ARO-SOD1, an siRNA Therapy for SOD1-ALS Title: Novel TRiMTM Platform for Delivery of RNAi Therapeutics to Adipose Tissue |
|
May 14, 2024 9:30 AM EDT
|
||
May 16, 2024 8:40 AM PDT
|
||
May 17 - May 22, 2024
|
Title: A First-in-Human Study of ARO-RAGE, a Novel Inhaled RNA-Interference Therapy for Asthma Title: A lung-targeted therapeutic siRNA against highly conserved viral M1 mRNAs effectively limits highly pathogenic influenza A infection in mice Title: Lung-targeted RNAi molecules silence human TSLP expression in PCLS cultures and humanized mice and suppress pulmonary allergic inflammation |
|
May 20 - May 24, 2024
|
Title: Liver-targeted therapeutic siRNAs against highly conserved yellow fever virus genomic sequences effectively limit infection and mortality in a hamster model
Date/Time: May 22, 2024, 10:45 a.m. AEST Presenter: Justin Julander, Ph.D. Session: Lipid Lowering via Novel Pathways |
|
May 23, 2024 2:00 PM EDT
|
||
May 26 - May 29, 2024
|
Title: PLOZASIRAN (ARO-APOC3), DECREASES APOC3 AND TRIGLYCERIDES (TG) IN PATIENTS WITH MIXED DYSLIPIDEMIA: MUIR FINAL RESULTS Title: PLOZASIRAN (ARO-APOC3), AN INVESTIGATIONAL RNAI THERAPEUTIC, DEMONSTRATES PROFOUND AND DURABLE REDUCTIONS IN APOC-3 AND TRIGLYCERIDES (TG) IN PATIENTS WITH SEVERE HYPERTRIGLYCERIDEMIA (SHTG), SHASTA-2 FINAL RESULTS Title: ZODASIRAN SILENCES HEPATIC ANGPTL3 LEADING TO DEEP AND DURABLE REDUCTIONS IN ATHEROGENIC LIPIDS AND LIPOPROTEINS IN MIXED DYSLIPIDEMIA PATIENTS: FINAL RESULTS FROM ARCHES-2, DOUBLE-BLIND PERIOD |
|
May 30 - Jun 2, 2024
|
Title: ENCORE - PLOZASIRAN (ARO-APOC3), DECREASES APOC3 AND TRIGLYCERIDES (TG) IN PATIENTS WITH MIXED DYSLIPIDEMIA: MUIR FINAL RESULTS Title: ENCORE - PLOZASIRAN (ARO-APOC3), AN INVESTIGATIONAL RNAI THERAPEUTIC, DEMONSTRATES PROFOUND AND DURABLE REDUCTIONS IN APOC-3 AND TRIGLYCERIDES (TG) IN PATIENTS WITH SEVERE HYPERTRIGLYCERIDEMIA (SHTG), SHASTA-2 FINAL RESULTS |
|
Jun 25, 2024
|
Archived Events
Date | Event Details |
---|---|
Apr 6 - Apr 8, 2024
|
View Presentation 885.9 KB
|
Mar 13, 2024 8:00 AM EDT
|
|
Mar 6, 2024 9:10 AM EST
|
|
Mar 3 - Mar 6, 2024
|
View Presentation 1.7 MB
|
Feb 6, 2024 4:30 PM EST
|
Prepared Remarks 207.6 KB
|
Jan 8, 2024 8:15 AM PST
|
View Presentation 1 MB
|